Parkinson
Products Related to Parkinson(73)
- GC18517DiapocyninCAS: 29799-22-2Purity: >98%
Diapocynin is the dimeric form of the NADPH oxidase inhibitor apocynin that has anti-inflammatory and antioxidant activities.
- GC19799Selegiline hydrochlorideCAS: 14611-52-0Purity: >98.00%
Selegiline hydrochloride is a selective monoamine oxidase B inhibitor used in the treatment of Parkinson's disease and major depressive disorder.
- GC19831SCD1 inhibitor-4CAS: 1295541-87-5Purity: >98.50%
مثبط SCD1-4 هو مثبط قوي وفعال عن طريق الفم stearoylCoA desaturase-1 (SCD1)
- GC26151(−)-Apomorphine (hydrochloride hydrate)CAS: 58117-94-5Purity: >95.00%
(-)-Apomorphine (hydrochloride hydrate) acts as a potent dopamine receptor agonist with a broad spectrum on all D1- and D2-like receptors (D1, D2S, D2L, D3, D4, D5).
- GC40078Memantine-d6 (hydrochloride)CAS: 1189713-18-5Purity: >99.00%
Memantine-d6 is intended for use as an internal standard for the quantification of memantine by GC- or LC-MS.
- GC40616Des-4-fluorobenzyl MosaprideCAS: 152013-26-8Purity: >96.00%
Des-4-fluorobenzyl Mosapride is the primary metabolite of mosapride.
- GC40834cis-EntacaponeCAS: 145195-63-7Purity: >98.00%
cis-Entacapone is a metabolite of the catechol-O-methyltransferase (COMT) inhibitor entacapone.
- GC42954BMS 470539 (hydrochloride)CAS: 2341796-82-3Purity: >99.50%
BMS 470539 (hydrochloride) is a highly selective and potent melanocortin-1 receptor (MC-1R) agonist. In cAMP accumulation assays, its EC 50 values for human and mouse MC1R are 16.8 and 11.6nM, respectively.
- GC43022C14 Ceramide (d18:1/14:0)CAS: 34227-72-0Purity: >97.00%
C14 Ceramide (d18:1/14:0) is an endogenous sphingolipid molecule produced by ceramide synthase 6.
- GC43274CitromycetinCAS: 478-60-4Purity: >95.00%
Citromycetin هو مركب عطري متعدد الكيتيدات من البنسليوم البري الأسترالي المشتق من البحار
- GC44270N-(α-Linolenoyl) TyrosineCAS: 259143-19-6Purity: >97.00%
Certain chronic neurologic disorders, such as Parkinson's disease, are caused by an insufficiency of the neurotransmitter dopamine secondary to the degeneration of substantia nigra dopaminergic neurons.
- GC44387Neurotensin (trifluoroacetate salt)Purity: >95.00%
Neurotensin (trifluoroacetate salt) is a neuropeptide composed of 13 amino acids, which functions as a neurotransmitter, hormone, and neuromodulator.
- GC45763Tolcapone-d4CAS: 1246816-93-2Purity: >99.00%
An internal standard for the quantification of tolcapone
- GC45802Zonisamide-13C2,15NCAS: 1188265-58-8Purity: >95.00%
An internal standard for the quantification of zonisamide
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC18517 | Diapocynin | 29799-22-2 | >98% | |
Diapocynin is the dimeric form of the NADPH oxidase inhibitor apocynin that has anti-inflammatory and antioxidant activities. | ||||
| GC18580 | B355252 | 1261576-81-1 | >98% | |
B355252 ، جزيء صغير فينوكسي ثيوفين سلفوناميد ، هو ناهض قوي لمستقبل NGF. | ||||
| GC19799 | Selegiline hydrochloride | 14611-52-0 | >98.00% | |
Selegiline hydrochloride is a selective monoamine oxidase B inhibitor used in the treatment of Parkinson's disease and major depressive disorder. | ||||
| GC19831 | SCD1 inhibitor-4 | 1295541-87-5 | >98.50% | |
مثبط SCD1-4 هو مثبط قوي وفعال عن طريق الفم stearoylCoA desaturase-1 (SCD1) | ||||
| GC20091 | α-Arbutin | 84380-01-8 | >99.00% | |
α-Arbutin (4-Hydroxyphenyl α-D-glucopyranoside) is emerging as popular and effective skin whiteners, acting as tyrosinase inhibitor. | ||||
| GC26151 | (−)-Apomorphine (hydrochloride hydrate) | 58117-94-5 | >95.00% | |
(-)-Apomorphine (hydrochloride hydrate) acts as a potent dopamine receptor agonist with a broad spectrum on all D1- and D2-like receptors (D1, D2S, D2L, D3, D4, D5). | ||||
| GC26338 | α-Cypermethrin | 67375-30-8 | >99.00% | |
| GC39481 | BL-918 | 2101517-69-3 | >98.00% | |
BL-918 هو منشط كيناز 1 (ULK1) شبيه بـ UNC-51 مع EC50 من 24.14 نانومتر | ||||
| GC40078 | Memantine-d6 (hydrochloride) | 1189713-18-5 | >99.00% | |
Memantine-d6 is intended for use as an internal standard for the quantification of memantine by GC- or LC-MS. | ||||
| GC40616 | Des-4-fluorobenzyl Mosapride | 152013-26-8 | >96.00% | |
Des-4-fluorobenzyl Mosapride is the primary metabolite of mosapride. | ||||
| GC40834 | cis-Entacapone | 145195-63-7 | >98.00% | |
cis-Entacapone is a metabolite of the catechol-O-methyltransferase (COMT) inhibitor entacapone. | ||||
| GC40945 | DOPAL | 5707-55-1 | >90.00% | |
DOPAL is an aldehyde product of the oxidative deamination of dopamine by monoamine oxidase. | ||||
| GC42954 | BMS 470539 (hydrochloride) | 2341796-82-3 | >99.50% | |
BMS 470539 (hydrochloride) is a highly selective and potent melanocortin-1 receptor (MC-1R) agonist. In cAMP accumulation assays, its EC 50 values for human and mouse MC1R are 16.8 and 11.6nM, respectively. | ||||
| GC43022 | C14 Ceramide (d18:1/14:0) | 34227-72-0 | >97.00% | |
C14 Ceramide (d18:1/14:0) is an endogenous sphingolipid molecule produced by ceramide synthase 6. | ||||
| GC43188 | CAY10680 | 1439488-21-7 | >98.00% | |
CAY10680 is a dopamine-sparing, benzothiazinone compound that selectively inhibits both MAO-B activity (IC50 = 34.9 nM in human) and adenosine A2A receptors (Ki = 39.5 nM in human). | ||||
| GC43274 | Citromycetin | 478-60-4 | >95.00% | |
Citromycetin هو مركب عطري متعدد الكيتيدات من البنسليوم البري الأسترالي المشتق من البحار | ||||
| GC44270 | N-(α-Linolenoyl) Tyrosine | 259143-19-6 | >97.00% | |
Certain chronic neurologic disorders, such as Parkinson's disease, are caused by an insufficiency of the neurotransmitter dopamine secondary to the degeneration of substantia nigra dopaminergic neurons. | ||||
| GC44335 | NCGC607 | 1462267-07-7 | >98.00% | |
NCGC607 is a salicylic acid derivative and small molecule glucocerebrosidase (GCase) chaperone. | ||||
| GC44387 | Neurotensin (trifluoroacetate salt) | - | >95.00% | |
Neurotensin (trifluoroacetate salt) is a neuropeptide composed of 13 amino acids, which functions as a neurotransmitter, hormone, and neuromodulator. | ||||
| GC44556 | PAQ | 943902-10-1 | >95.00% | |
PAQ is a neuroprotective agent. | ||||
| GC45509 | Melanocyte-Stimulating Hormone Release-Inhibiting Factor (trifluoroacetate salt) | - | >95.00% | |
| ||||
| GC45557 | Safinamide-d4 | 2748522-33-8 | >99.00% | |
| ||||
| GC45763 | Tolcapone-d4 | 1246816-93-2 | >99.00% | |
An internal standard for the quantification of tolcapone | ||||
| GC45802 | Zonisamide-13C2,15N | 1188265-58-8 | >95.00% | |
An internal standard for the quantification of zonisamide | ||||
